Safety of rituximab for remission maintenance in relapsing ANCA-associated vasculitis: repeat cycles on clinical relapse are associated with low rates of hypogammaglobulinemia

Category Primary study
JournalNE Rheumatology Issue
Year 2013
This article has no abstract
Epistemonikos ID: c028e9d5adafbd49abc21880ec87a27d7484a4f8
First added on: Apr 10, 2015